$1.69
-0.155[-8.40%]
At close: Apr 22
$1.69
0[0.00%]
After Hours: 4:01PM EDT
Sonnet BioTherapeutics
(NASDAQ:SONN)Sonnet BioTherapeutics Stock (NASDAQ:SONN), Earnings Estimates, EPS, and Revenue
Sonnet BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$0.130
Quarterly Revenue Estimate
$10K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$129.2K
Analyze the earnings history of Sonnet BioTherapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | AM | SONN | Q2 | -$7.48 | $0.13 | — | — | $36.45K | $10.00K | — | — | Get Alert |
| 02/14/2024 | AM | SONN | Q1 | -$17.60 | -$0.90 | -$0.31 | 65.56% | $37.26K | $20.00K | $18.63K | -6.87% | Get Alert |
| 12/14/2023 | AM | SONN | Q4 | -$36.52 | -$0.90 | -$0.78 | 13.33% | $62.75K | $20.00K | $37.26K | 86.27% | Get Alert |
| 08/14/2023 | AM | SONN | Q3 | -$40.04 | -$6.82 | -$2.86 | 5806.45% | $62.07K | — | $36.85K | — | Get Alert |
| 05/10/2023 | AM | SONN | Q2 | -$42.02 | — | -$7.48 | — | $95.32K | — | $36.45K | — | Get Alert |
| 02/13/2023 | AM | SONN | Q1 | -$30.80 | — | -$17.60 | — | $129.80K | — | $37.26K | — | Get Alert |
| 12/15/2022 | AM | SONN | Q4 | -$27.72 | — | -$36.52 | — | $0.00 | — | $62.75K | — | Get Alert |
| 08/15/2022 | PM | SONN | Q3 | -$83.16 | — | -$40.04 | — | $0.00 | — | $62.07K | — | Get Alert |
| 05/10/2022 | AM | SONN | Q2 | -$98.56 | — | -$43.12 | — | $0.00 | — | $95.32K | — | Get Alert |
| 02/08/2022 | AM | SONN | Q1 | -$104.72 | — | -$30.80 | — | $0.00 | — | $129.80K | — | Get Alert |
| 12/17/2021 | AM | SONN | Q4 | -$1.46K | — | -$27.72 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/16/2021 | AM | SONN | Q3 | -$135.52 | — | -$83.16 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/17/2021 | AM | SONN | Q2 | -$15.40 | — | -$98.56 | — | $0.00 | — | $0.00 | — | Get Alert |
| 02/16/2021 | AM | SONN | Q1 | -$135.52 | — | -$104.72 | — | — | — | $0.00 | — | Get Alert |
| 12/17/2020 | AM | SONN | Q4 | — | — | -$1.46K | — | — | — | $0.00 | — | Get Alert |
| 08/14/2020 | AM | SONN | Q3 | — | — | -$135.52 | — | — | — | $0.00 | — | Get Alert |
| 05/18/2020 | AM | SONN | Q2 | — | — | -$15.40 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?
Sonnet BioTherapeutics (SONN) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on February 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Sonnet BioTherapeutics (NASDAQ:SONN)?
The Actual EPS was $-0.31, which beat the estimate of $-0.90.
What were Sonnet BioTherapeutics’s (NASDAQ:SONN) revenues?
The Actual Revenue was $18.6K, which missed the estimate of $20K.
Browse earnings estimates, EPS, and revenue on all stocks.